Inspira™ Technologies Announces Business Targets Presentation Following FDA Clearance and Significant Developments

Core Insights - Inspira Technologies OXY B.H.N. Ltd. announced a conference call to discuss business targets and distribution agreements following FDA clearance for the INSPIRA ART100 system [1][2] Company Overview - Inspira Technologies is an innovative medical technology company focused on life support, with products designed to enhance patient care [3] - The INSPIRA ART (Gen 2), also known as INSPIRA ART500, utilizes Adaptive Blood Oxygenation technology to measure blood parameters in real-time and deliver oxygen directly into the blood [3] - This technology aims to elevate patient oxygen saturation levels quickly, potentially allowing patients to remain awake during treatment and reducing reliance on mechanical ventilation [3] Regulatory Milestones - The company received FDA 510(k) clearance for the INSPIRA ART100, a Cardiopulmonary Bypass System [4] - Other products, including the INSPIRA ART (Gen 2) and HYLA blood sensor, have not yet been tested in humans and lack regulatory approval [4]